Rosen National Trial Lawyers Urges Investors of GigaCloud Technology Inc. to Seek Counsel Before Securities Class Action Deadline

Rosen National Trial Lawyers Urges Investors of GigaCloud Technology Inc. to Seek Counsel Before Securities Class Action Deadline NEW YORK, Nov. 11, 2023 (GLOBE NEWSWIRE) Introduction Rosen Law Firm, a global investor rights law firm, is urging investors of GigaCloud Technology Inc. (NASDAQ: GCT) to seek counsel before the securities class action deadline. This reminder…

Read More

Mineralys Therapeutics Takes a Unique Approach to Treating Uncontrolled Hypertension with Lorundrostat: AHA Scientific Sessions 2023 Recap

Mineralys Therapeutics Takes a Unique Approach to Treating Uncontrolled Hypertension with Lorundrostat: AHA Scientific Sessions 2023 Recap The Groundbreaking Research At the recent American Heart Association Scientific Sessions 2023, Mineralys Therapeutics presented new findings from their Target-HTN Phase 2 trial that are set to revolutionize the treatment of uncontrolled hypertension. The study focused on the…

Read More

Attention Shareholders: Kaskela Law LLC Launches Investigation into Seres Therapeutics Inc. (NASDAQ: MCRB) – Take Action Now!

Investigation of Seres Therapeutics, Inc. (NASDAQ: MCRB) SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Seres Therapeutics, Inc. (NASDAQ: MCRB) (“Seres”) on behalf of the company’s investors. Since June 2023, shares of Seres’ common stock have declined in value from a…

Read More

Calling All Investors: Kaskela Law LLC Investigates Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) – Don’t Miss Out on This Shareholder Alert!

Investigating Phathom Pharmaceuticals, Inc. SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) Philadelphia, Nov. 11, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) (“Phathom”) on behalf of the company’s investors. Since August 2023, shares of Phathom’s common stock have declined in…

Read More

Calling all Shareholders: Kaskela Law LLC is on the Case for Avidity Biosciences Inc. (NASDAQ: RNA)! Don’t Miss Out – Contact Them Now!

Delving into the Avidity Biosciences Investigation A Closer Look at the Situation As news of Kaskela Law LLC’s investigation into Avidity Biosciences, Inc. (NASDAQ: RNA) surfaces, investors are left wondering about the implications of this development. The decline in Avidity’s stock price since February 2023 has certainly raised eyebrows among stakeholders, with shares dropping significantly…

Read More

Attention Investors: A Class Action Lawsuit Has Been Filed Against SolarEdge Technologies Inc. – Here’s What You Need to Know!

Are Solar Panels Really Worth It? A Closer Look at SolarEdge Technologies, Inc. Introduction Have you ever considered investing in solar panels for your home? With the rising cost of traditional energy sources and the increasing focus on sustainable living, solar panel technology has become more popular than ever. However, recent news about SolarEdge Technologies,…

Read More